乳腺癌查:不仅仅是死亡率
Martin J Yaffe1,2, Roberta A Jong2, Kathleen I Pritchard3
1Sunnybrook Health Sciences Centre and The University of Toronto, Departments of Medical Biophysics, Toronto, ON, Canada.
Journal of breast imaging
|March 1, 2024
概括
评估乳腺癌查的有效性需要考虑获得的生命年数和减少的治疗发病率,而不仅仅是死亡率. 量化查的危害与好处一起提供了更完整的画面.
科学领域:
- 在瘤学瘤学.
- 公共卫生 公共卫生
- 卫生经济学 卫生经济学
背景情况:
- 传统乳腺癌查的有效性是通过死亡率的降低来衡量的.
- 这一指标可能无法完全捕捉疾病负担,特别是在年轻女性身上.
- 治疗发病率和查危害在评估中经常被忽视.
研究的目的:
- 讨论和量化乳腺癌查有效性的替代指标.
- 将获得的生命年数和质量调整的生命年数 (QALYs) 纳入查评估.
- 通过量化查的好处和危害,提供一个平衡的视角.
主要方法:
- 审查和讨论用于评估查有效性的替代指标.
- 通过早期发现乳腺癌获得的生命年和QALY的量化.
- 分析与早期检测相关的与治疗相关的发病情况.
- 评估和量化癌症查的危害和局限性.
主要成果:
- 仅仅是减少死亡率可能会低估乳腺癌查的真正价值.
- 获得的生命年和QALY提供了更全面的查效益衡量标准.
- 早期检测可以减少治疗致病率,这是一个经常被忽视的好处.
- 查的危害经常被低估,并且相对于益处缺乏前景.
结论:
- 获得寿命年和QALY等替代指标提供了对乳腺癌查有效性的更全面的看法.
- 将降低的发病率和量化的危害纳入其中,可以提供更准确的风险效益分析.
- 更广泛的评估框架对于理解乳腺癌查对个人和社会的全部影响至关重要.
相关概念视频
Cancer Survival Analysis
345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345
Preventive Healthcare Services
1.0K
Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
1.0K
Actuarial Approach
78
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
78
Kaplan-Meier Approach
137
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
137


